Related Experiment Videos
Age-related decline in central cholinergic function demonstrated with scopolamine
1Department of Psychiatry, University of Rochester School of Medicine and Dentistry, New York, USA.
Psychopharmacology
|May 1, 1996
Summary
Older adults show increased sensitivity to scopolamine, a drug affecting cognitive functions. This study found age significantly correlates with scopolamine-induced impairments in memory and motor skills.
Area of Science:
- Pharmacology
- Neuroscience
- Gerontology
Background:
- Scopolamine is an anticholinergic drug known to induce cognitive deficits.
- Aging is associated with changes in cognitive function and drug sensitivity.
Purpose of the Study:
- To investigate the dose-dependent effects of scopolamine on cognitive functions in normal adults.
- To examine the relationship between age and scopolamine-induced cognitive impairments.
Main Methods:
- A double-blind, placebo-controlled, randomized study involving 23 normal subjects (40-89 years).
- Intravenous administration of scopolamine hydrobromide at doses of 0.1 mg, 0.25 mg, and 0.5 mg.
- Assessment using a comprehensive cognitive test battery, behavioral, and physiological measures.
Main Results:
- Scopolamine caused dose-dependent cognitive impairments, particularly in psychomotor speed, short-term recall, visual tracking, visuo-motor coordination, and sequencing.
- Age significantly correlated with scopolamine-impaired performances across multiple cognitive domains.
- Behavioral and physiological effects were minimal, with some inter-individual variability observed.
Conclusions:
- Cholinergically mediated cognitive functions exhibit heightened sensitivity to scopolamine in older adults.
- Age-related increases in scopolamine sensitivity suggest potential implications for medication management in the elderly.
- Further research is warranted to understand the heterogeneity of this age-related phenomenon.